QIAGEN N.V. (NYSE:QGEN) Q1 results:
Sales: $372.1M (+6.7%).
Molecular diagnostics revenue up 4% to $176M.
Net income: $39.8M (+34.9%); EPS: $0.17 (+30.8%); non-GAAP EPS: $0.34 (+25.9%).
Cash flow ops: $15.9M (-64.4%).
Q2 guidance: Sales growth at least 12%; non-GAAP EPS at least $0.40.
2020 guidance withdrawn.
https://seekingalpha.com/news/3570589-qiagen-q1-sales-up-7-increased-growth-expected-this-quarter
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.